Search results for: “14”

  • CPIC® Guideline for Ivacaftor and CFTR

    Most recent guideline publication: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Ivacaftor Therapy in the Context of CFTR Genotype (March 2014) Updates since publication: May 2019: The FDA-approved drug label for ivacaftor has been updated to include additional variants, bringing the total number of indicated variants to 38. The CPIC guideline supplement and CFTR Allele…

  • CPIC® Guideline for Opioids and CYP2D6, OPRM1, and COMT

    Most recent guideline publication: Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, OPRM1, and COMT genotype and select opioid therapy (December 2020) Tables and figure provided in the main manuscript of the guideline: Table 1. Assignment of predicted CYP2D6 phenotypes based on diplotypes Table 2. Codeine therapy recommendations based on CYP2D6 phenotype Table 3. Tramadol…

  • CPIC® Guideline for Selective Serotonin Reuptake Inhibitors and CYP2D6 and CYP2C19

    Most recent guideline publication: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors (August 2015) Updates since publication: October 2019: CYP2D6 genotype to phenotype translation changes: Up until August 2019, there were a few inconsistencies in the translation of CYP2D6 genotype to phenotype across guidelines (i.e.…

  • CPIC® Guideline for HLA genotype and Use of Carbamazepine and Oxcarbazepine

      Most recent guideline publication Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update (December 2017) Updates since publication: No updates on dosing recommendations since publication. Tables provided in the main manuscript of the guideline: Table 1. Assignment of HLA-B and HLA-A genotypes Table 2. Recommendations for…

  • CPIC® Guideline for Fluoropyrimidines and DPYD

    Most recent guideline publication: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update (October 2017) Updates since publication: January 2024 update (edited March 2024): Recently, individual patients have been reported (PMID 38129972) to carry only one of the two SNPs in the HapB3 haplotype (i.e., c.1236G>A without c.1129-5923C>G), suggesting…

  • CPIC® Guideline for Atazanavir and UGT1A1

    Most recent guideline publication: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for UGT1A1 and Atazanavir Prescribing (September 2015) Updates since publication: November 2017: UGT1A1*80 is in very high linkage disequilibrium with *28 and *37. In the rare event that *80 is detected but *28 and *37 are not, there are not enough clinical data to predict…

  • CPIC® Guideline for Tricyclic Antidepressants and CYP2D6 and CYP2C19

    Most recent guideline publication: Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update (December 2016) Updates since publication: October 2019: CYP2D6 genotype to phenotype translation changes: Up until August 2019, there were a few inconsistencies in the translation of CYP2D6 genotype to phenotype across guidelines (i.e.…

  • Implementation

    The following is a list of PGx implementers who are using CPIC guidelines as part of a program to facilitate use of genetic tests to guide prescribing for patients in clinical care settings: Institution Website and/or Contact (if available) AIG Hospitals, Hyderabad, India AIG Hospitals Allina Health Christine Kroger; Christine.Kroger@allina.com Arkansas Children’s Hospital Arkansas Children’s…

  • CPIC® Guideline for Abacavir and HLA-B

    Most recent guideline publication: Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing (April 2012) Updates since publication: May 2014 : Guideline authors reviewed additional literature and concluded that none of the evidence would change the therapeutic recommendations in the 2012 guideline; therefore, the 2012 guideline remains clinically current. The guideline supplement and…

  • Contact (old)

    CPIC Communication There are a few different ways to stay in touch with CPIC. I have a question or comment. Contact us with any questions or comments Contact CPIC I want to get announcements. CPIC has a public announcement list that anyone can join.The announcements include guideline updates, news, and solicitation of feedback. Sign Up…